Copyright
©The Author(s) 2021.
World J Gastroenterol. Jun 14, 2021; 27(22): 3109-3120
Published online Jun 14, 2021. doi: 10.3748/wjg.v27.i22.3109
Published online Jun 14, 2021. doi: 10.3748/wjg.v27.i22.3109
Table 4 Comparison of biological data ratio after tacrolimus induction
Rate of biological data | Remission (n = 30) | Failure (n = 17) | P value |
Week 1/week 0 Alb ratio | 1.05 ± 0.14 | 1.02 ± 0.13 | 0.429 |
Week 2/week 0 Alb ratio | 1.19 ± 0.20 | 1.02 ± 0.16 | 0.003 |
Week 1/week 0 CRP ratio | 0.28 ± 0.49 | 1.28 ± 3.80 | 0.159 |
Week 2/week 0 CRP ratio | 0.16 ± 0.23 | 1.42 ± 4.28 | 0.112 |
Week 1/week 0 Hb ratio | 0.96 ± 0.13 | 1.01 ± 0.18 | 0.315 |
Week 2/week 0 Hb ratio | 0.97 ± 0.13 | 0.98 ± 0.14 | 0.892 |
Week 1/week 0 WBC ratio | 0.77 ± 0.32 | 0.84 ± 0.33 | 0.520 |
Week 2/week 0 WBC ratio | 0.72 ± 0.30 | 0.86 ± 0.40 | 0.194 |
- Citation: Ishida N, Miyazu T, Tamura S, Tani S, Yamade M, Iwaizumi M, Hamaya Y, Osawa S, Furuta T, Sugimoto K. Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome. World J Gastroenterol 2021; 27(22): 3109-3120
- URL: https://www.wjgnet.com/1007-9327/full/v27/i22/3109.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i22.3109